Search Results - "Sabato, Philip E"
-
1
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection
Published in Clinical pharmacology and therapeutics (01-12-2020)“…Chloroquine and hydroxychloroquine are quinoline derivatives used to treat malaria. To date, these medications are not approved for the treatment of viral…”
Get full text
Journal Article -
2
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections
Published in Antimicrobial agents and chemotherapy (17-11-2021)“…Tedizolid phosphate is an oxazolidinone antibacterial agent approved for the treatment of Gram-positive acute bacterial skin and skin structure infections…”
Get full text
Journal Article -
3
Discovery of Methyl 4′-Methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate, an Improved Small-Molecule Inhibitor of c-Myc-Max Dimerization
Published in ChemMedChem (01-10-2014)“…c‐Myc is a basic helix‐loop‐helix‐leucine zipper (bHLH‐ZIP) transcription factor that is responsible for the transcription of a wide range of target genes…”
Get full text
Journal Article -
4
Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5
Published in Oncotarget (01-06-2013)“…The c-Myc (Myc) oncoprotein is a high-value therapeutic target given that it is deregulated in multiple types of cancer. However, potent small molecule…”
Get full text
Journal Article -
5
Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
Published in Oncotarget (12-10-2018)“…[This corrects the article DOI: 10.18632/oncotarget.1108.]…”
Get full text
Journal Article -
6
590. Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model
Published in Open forum infectious diseases (15-12-2022)“…Abstract Background Cefepime-taniborbactam (FTB) combines cefepime (FEP), a fourth generation cephalosporin with taniborbactam, a novel inhibitor of metallo…”
Get full text
Journal Article